Contract 75N93019C00070
Seattle Children'S Hospital · Department Of Health And Human Services · August 27, 2024
Seattle Children'S Hospital was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on August 27, 2024 for $20.11 million of work in research and development in biotechnology (except nanobiotechnology). Performance is in Seattle, WA. It was awarded under full and open competition. The contract has been modified 1 time since the base award It uses cost no fee contract pricing. The most recent modification was on September 25, 2025. If all options are exercised, the contract could reach $86.60 million.
Contract details
- PIID
- 75N93019C00070
- Award type
- Definitive Contract
- Pricing
- Cost No Fee
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Applied Research
- Place of performance
- Seattle, WA
- First action
- August 27, 2024
- Latest action
- September 25, 2025
Description
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CONSORTIUM AND EOI::EO: RADICAL TRANSPARENCY ABOUT WASTEFUL SPENDING
Modification timeline
-
September 25, 2025Mod P00024 · Change Order$86.60M
-
August 27, 2024Mod P00021 · Exercise An OptionIMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER (IMPAC-TB)$81.79M
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Vericel Corporation | Department Of Health And Human Services | April 1, 2026 | $34.88M |
| American College Of Medical Toxicology, Inc. | Department Of Health And Human Services | March 31, 2026 | $0 |
| Ceramedix Holding, Llc | Department Of Health And Human Services | March 31, 2026 | $4.22M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | March 31, 2026 | $7.79M |
| Care Access Research Llc | Department Of Health And Human Services | March 31, 2026 | $2.55M |
| Pattern Bioscience, Inc. | Department Of Health And Human Services | March 31, 2026 | $22.50M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N93019C00070?
Contract 75N93019C00070 is a federal contract awarded to Seattle Children'S Hospital by Department Of Health And Human Services on August 27, 2024 for $20.11 million of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 1 time since the base award.
Who won contract 75N93019C00070?
Seattle Children'S Hospital won contract 75N93019C00070 from Department Of Health And Human Services.
How much is contract 75N93019C00070 worth?
Contract 75N93019C00070 has obligated $20.11 million to date, with a total potential value of $86.60 million if all options are exercised.